TRUS biopsy Archives - Page 4 of 4 - Sperling Prostate Center

Get Your Annual PSA Blood Test!

Do you get an annual physical or wellness check? Is a PSA blood test part of it? If it isn’t, it might be because your doctor took to heart the 2012 bulletin from the US Preventive Services Task Force panel regarding PSA screening. That year, the USPSTF downgraded PSA screening to a D (not recommended keep reading

How Much Can You Know About Your Prostate Cancer Before Treatment?

Doctor speaking with patient about prostate cancer treatment options

Prostate cancer is a complex disease, and understanding the full extent of it is crucial before making treatment decisions. Multiparametric MRI (mpMRI) offers a detailed view of your prostate, helping to identify critical information to guide your treatment plan. keep reading

How to Increase the Odds for Successful Active Surveillance

Let’s start with a short quiz: What is the current preferred strategy to manage low-risk prostate cancer? a) Nerve-sparing robotic prostatectomy b) Focal treatment c) Active Surveillance d) Vitamin E, saw palmetto supplements, and avoid red meat If you answered “c) Active Surveillance,” you are correct. According to a 2017 joint guideline statement from four keep reading

Multiparametric MRI Before Prostate Biopsy: Dawn of a New Era

“Change is inevitable. Progress is optional.” Tony Robbins In medicine, change sometimes happens with two steps forward but one step back. For example, in the early 20th century, delivering babies in hospitals became more popular than home births in order to have “painless” births with anesthesia. However, for many women the higher complication and infection keep reading

British Study Confirms the Role of mpMRI Before Biopsy

Terrific news and a great way to start off 2017! On January 17, the prestigious medical journal The Lancet issued online publication of a British study, “Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study” (Ahmed et al., 2017[i]). This large trial validated the importance of multiparametric keep reading

Multiparametric MRI Can Save Millions of Healthcare Dollars

It’s time to silence the economic naysayers who claim that multiparametric MRI (mpMRI) is too expensive for detecting and diagnosing prostate cancer. Results from a new study out of Brigham and Women’s Hospital[i] (Boston, MA) in partnership with AdMeTech reflect how the Sperling Prostate Center has been ahead of its time. The study demonstrates how keep reading

New Studies to Watch For

By: Dan Sperling, MD Many focal laser ablation patients, and those considering this targeted prostate cancer treatment, are eagerly anticipating the May 15-19 American Urological Association meeting in New Orleans. Given that the majority of urologists are not exactly FLA-friendly, why would fans of our pioneering and elegant therapy set their sights on this meeting? keep reading

TRUS Biopsy: Still Trying to Solve the Riddle

Matt Mullenweg, the originator of the popular open source WordPress software, has been quoted as saying, “Whenever there’s a new form of media, we always think it’s going to replace the old thing, and it never does. We still have radio, however long after TV was introduced.” It can be just as true in medicine. keep reading

Tag: TRUS biopsy